Rush University is testing Apple Vision Pro headsets paired with AI during colonoscopies in a usability trial that could inform an FDA submission and wider hospital use.

Northwestern and Lurie Children’s unveiled a hair‑thin probe that measures fetal heart rate, oxygen and temperature during in‑utero surgery.

Chicago startups raised about $2.6 billion in 2025 as national VC totals surged on AI megadeals, leaving local backers worried that the Midwest is being bypassed.

AbbVie paid $650M up front to license RemeGen's RC148 outside China; the deal and a Tempe plant purchase underscore a fresh push into oncology and U.S. manufacturing.

The Chicago Tribune joined other newsrooms in asking a Manhattan judge to sanction OpenAI, alleging the company deleted and substituted millions of ChatGPT logs.

A man was injured in a stabbing during an altercation on Chicago's CTA Blue Line. The victim was taken to the hospital and is in good condition. No arrests have been made, and police are investigating.

A new ranking puts Chicago at No. 9 for startups — strong survival rates, but the city lags in new business formation.

A computational mismatch helped researchers identify residual water blocking COF capture sites — making pores hydrophobic during synthesis restores CO2 uptake.

An international 4D Nucleome team produced single‑cell 3D genome maps, cataloging 140,000+ chromatin loops and offering new ways to link non‑coding variants to disease.

Northwestern researchers report NU‑9 lowered a newly discovered toxic amyloid‑beta oligomer and blunted early brain inflammation in mice, pointing to a possible pre‑symptomatic intervention.

Chicago Christian students finished first and second at the South Suburban robotics meet and were tapped to represent Illinois at the United States Governor's Cup in D.C.

NMSU and Northwestern astronomers reprocessed archived telescope data to directly image HD 143811 AB b — a roughly five‑Jupiter‑mass planet orbiting twin stars. The find gives a rare window into planet formation around binaries.

Syntax Bio's Science Advances paper introduces 'Cellgorithm', a CRISPR-based method that the company says can shrink stem-cell differentiation from months to days. The approach could speed regenerative therapies if it scales.